Acorda Therapeutics, Inc. (Nasdaq: ACOR) and Biotie Therapies Corp. (“Biotie” or the "Company") have entered into a combination agreement ("Combination ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE